HomeHealth & FitnessCan everyday medicines like Ibuprofen protect your brain from dementia? New research suggests hope

Can everyday medicines like Ibuprofen protect your brain from dementia? New research suggests hope

Common medicines, including diabetes, cancer, and antiviral drugs, may offer new hope in slowing dementia. UK researchers, including a team from the University of Cambridge, have uncovered strong links between everyday prescriptions and reduced risk of cognitive decline, opening doors to faster, cheaper trials that could benefit many. Here’s what you need to know

July 23, 2025 / 11:22 IST
Story continues below Advertisement
Study suggests people already taking common drugs like ibuprofen, certain antivirals, or flu vaccines seemed to have a consistently lower risk of developing dementia (Image: Pexels)
Study suggests people already taking common drugs like ibuprofen, certain antivirals, or flu vaccines seemed to have a consistently lower risk of developing dementia (Image: Pexels)

Did you know that the answer to one of the most feared brain diseases may be sitting in your medicine cabinet? Instead of chasing brand-new drugs, researchers are relooking at medicines already in use, from cancer treatments to diabetes meds, and finding signs they might just protect the ageing brain against dementia.

Researchers from the University of Cambridge and the University of Exeter joined hands to track over 130 million people and nearly a million diagnosed dementia cases. They found that people already taking common drugs like ibuprofen, certain antivirals, or flu vaccines seemed to have a consistently lower risk of developing dementia. These results were seen across multiple datasets and groups.

Story continues below Advertisement

As per the research, instead of relying solely on new pharmaceutical breakthroughs, which can take 10–15 years to reach patients, scientists now have a shortcut worth testing. Medicines that are already licensed for other conditions can enter dementia trials far more quickly, having already passed safety approvals. Dr Ben Underwood, part of the Cambridge team, said, “If we can find drugs already licensed for other conditions, we can get them into trials much, much faster.”

Similarly, a joint UK study published in Alzheimer’s and Dementia: Translational Research & Clinical Interventions found that antibiotics, anti‑inflammatories, and antivirals were associated with a reduced onset of dementia.